The Food and Drug Administration (FDA) approved BenlystaŽ (belimumab), a new biologic therapy developed to treat patients suffering from active, autoantibody-positive systemic lupus erythematosus (SLE). This landmark decision heralds the first new therapy developed and approved by the FDA specifically for lupus since 1955. According to Virginia T...

More...